# Nuveen NASDAQ 100 Dynamic Overwrite Fund: filings

QQQX · Nasdaq · CIK 1608741 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qqqx.md) · [Financials](/companies/qqqx/financials.md) · [Filings](/companies/qqqx/filings.md) · [Insiders](/companies/qqqx/insiders.md)

## Reports and events: 17 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 65, NPORT-P 28, 425 13, DEF 14A 12, N-CSR 12, N-CSRS 12, N-PX 12, 497 11, 424B3 9, N-CEN 8, N-Q 8, CORRESP 7, 8-K 5, POS EX 5, EFFECT 4, NSAR-B 4, NSAR-A 3, SC 13G/A 3, 4 2, 424B5 2, N-14 8C 2, N-2 2, N-2/A 2, N-2ASR 2, 144 1, 424B2 1, 486BPOS 1, 4/A 1, 8-A12B 1, CERTNAS 1, DEFA14A 1, N-14 8C/A 1, N-8A 1, NPORT-EX 1, N-PX/A 1, SC 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-03-03 | 22:29 ET | [DEF 14A](/filings/0001193125-26-088848.md) | Proxy statement, period 2026-04-16 | 0001193125-26-088848 |
| 2025-03-04 | 22:20 ET | [DEF 14A](/filings/0001193125-25-045736.md) | Proxy statement, period 2025-04-17 | 0001193125-25-045736 |
| 2024-03-06 | 19:59 ET | [8-K](/filings/0001193125-24-060585.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-060585 |
| 2024-02-27 | 20:55 ET | [DEF 14A](/filings/0001193125-24-047882.md) | Proxy statement, period 2024-04-12 | 0001193125-24-047882 |
| 2023-10-13 | 10:59 ET | [8-K](/filings/0001193125-23-255643.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-255643 |
| 2023-03-30 | 15:06 ET | [DEF 14A](/filings/0001193125-23-084813.md) | Proxy statement, period 2023-05-08 | 0001193125-23-084813 |
| 2022-02-25 | 12:04 ET | [8-K](/filings/0001193125-22-053181.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-053181 |
| 2022-02-24 | 22:07 ET | [DEF 14A](/filings/0001193125-22-052356.md) | Proxy statement, period 2022-04-08 | 0001193125-22-052356 |
| 2021-03-04 | 18:09 ET | [DEF 14A](/filings/0001193125-21-069115.md) | Proxy statement, period 2021-04-06 | 0001193125-21-069115 |
| 2020-10-06 | 00:18 ET | [8-K](/filings/0001193125-20-264175.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-264175 |
| 2020-03-02 | 21:35 ET | [DEF 14A](/filings/0001193125-20-059018.md) | Proxy statement, period 2020-04-08 | 0001193125-20-059018 |
| 2019-02-26 | 17:22 ET | [DEF 14A](/filings/0001193125-19-051482.md) | Proxy statement, period 2019-04-10 | 0001193125-19-051482 |
| 2018-02-23 | 22:19 ET | [DEF 14A](/filings/0001193125-18-056193.md) | Proxy statement, period 2018-04-11 | 0001193125-18-056193 |
| 2017-02-24 | 22:13 ET | [DEF 14A](/filings/0001193125-17-056543.md) | Proxy statement, period 2017-04-06 | 0001193125-17-056543 |
| 2016-03-10 | 21:18 ET | [DEF 14A](/filings/0001193125-16-500152.md) | Proxy statement, period 2016-04-22 | 0001193125-16-500152 |
| 2015-07-01 | 21:50 ET | [DEF 14A](/filings/0001193125-15-241565.md) | Proxy statement, period 2015-08-05 | 0001193125-15-241565 |
| 2014-12-22 | 20:42 ET | [8-K](/filings/0001193125-14-450502.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-14-450502 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.